Home > E-Books > Tumor (Western Medicine)
Tumor (Western Medicine)
Translated from the Chinese edition
Editor(s)-in-Chief:CHENG Maosheng
Publisher(s):China Academic Journals (CD Edition) Electronic Publishing House Co., Ltd.
ISBN:ISBN 978-7-499-00981-3 pdf

First Published: 2020.11.23
Discipline(s): Medicine & Public Health
Price: $99 (for individuals) (中国大陆地区个人用户点此直接购买)
 

Institution users and community members, please click here to contact us.

中国大陆地区机构用户, 请点击这里联系我们.

  • Tumor (Western Medicine), as part of China’s Medicine Progress Series, has 107 excellent articles on tumor treatment with western medicine. These articles were recommended by the editorial boards of the journals in which they were originally published in Chinese, covering comprehensive drug research, hematopoietic organ and lymphoid tumors, respiratory system tumor, nursing research, urogenital tumor, skin tumor, neurological tumor, and digestive system tumor. These articles fully demonstrate the cutting-edge advances in tumor treatment in China, with scientific methodological support and objective conclusions. The original articles were published in Chinese, and this book is a compilation of English version of selected articles.

  • CHENG Maosheng is currently serving as a director of Asian Federation for Medicinal Chemistry (AFMC), a director of Chinese Pharmaceutical Association, the vice chairman of the Specialized Committee on Medicinal Chemistry, Chinese Pharmaceutical Associati

Preview

1. Effect of family history of cancer on clinical features and prognostic factors of patients with nasopharyngeal carcinoma

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 01

2. Relationship between MAPK1 gene polymorphism and gefitinib hepatotoxicity in NSCLC patients with activating EGFR mutations

Acta Pharmaceutica Sinica,Part 3: Clinical Study,Vol 53,No. 02

3. Comparative analysis of immediate breast reconstruction after skin-sparing mastectomy and modified radical mastectomy in young breast cancer patients

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 03

4. Adverse reactions of chemoradiotherapy with docetaxel after modified radical mastectomy in locally advanced breast cancer

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 04

5. Clinical value of combining indocyanine green fluorescence navigation with methylene blue in sentinel lymph node biopsy in patients with breast cancer

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 05

6. Diagnosis value of ultrasound-guided core-needle biopsy in breast masses under BI-RADS categories 4A to 4C

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 44,No. 06

7. The effectiveness of computer-based monitoring system for patients with breast cancer receiving adjuvant hormonal therapy

Chinese Journal of Nursing,Part 3: Clinical Study,Vol 52,No. 07

8. A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in HER2-Positive Early Breast Cancer

Chinese Pharmaceutical Journal,Part 3: Clinical Study,Vol 52,No. 08

10. Design and clinical application of rehabilitation VR system for breast cancer patients

Chinese Journal of Nursing,Part 3: Clinical Study,Vol 53,No. 10

11. Development of continuing nursing evaluation system for patients with breast cancer

Chinese Journal of Nursing,Part 3: Clinical Study,Vol 54,No. 11

12. Consistency study of self-reports and nursing notes in adjuvant chemotherapy-related side effects among patients with breast cancer

Chinese Journal of Nursing,Part 3: Clinical Study,Vol 54,No. 12

13. Application and effect of virtual cognitive rehabilitation training in breast cancer patients with cognitive impairment after chemotherapy

Chinese Journal of Nursing,Part 3: Clinical Study,Vol 54,No. 13

14. A trajectory study of sleep and related symptoms in breast cancer patients based on ecological momentary assessment

Chinese Journal of Nursing,Part 3: Clinical Study,Vol 54,No. 14

15. Ultrasound-guided percutaneous nephrostomy for the treatment of cancer-related hydronephrosis: a report of 289 cases

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 15

16. Perioperative nursing of three patients undergoing resection with tumors involving intra-and extra-cranial regions and anterolateral femoral skin flap repair

Chinese Journal of Nursing,Part 3: Clinical Study,Vol 52,No. 16

17. Establishment and application of respiratory function training program for patients with postoperative dysphagia after posterior fossa tumor surgery

Chinese Journal of Nursing,Part 3: Clinical Study,Vol 53,No. 17

18. Microsurgical Treatment of Spinal Cord Congenital Tumors

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 18

19. Changes of circulating tumor cells in locally advanced esophageal squamous cell carcinoma patients treated with concurrent chemoradiotherapy

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 19

20. A comparative analysis of the incidence rates of esophageal cancer and upper gastrointestinal cancer in Cixian County, Hebei Province, China

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 44,No. 20

21. Analysis of short-and long-term outcomes after esophagectomy in elderly cancer patients

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 45,No. 21

22. Efficacy of S-1 combined with cisplatin as first-line chemotherapy for advanced AFP positive gastric cancer

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 22

23. Association of Serum PGE-2 and VEGF levels and the Expression of VEGF in Gastric Cancer Tissue and Clinicopathological Features of Gastric Carcinoma Patients with Hyperlipidemia

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 23

24. Correlation between preoperative NLR, PLR, and RDW and clinical pathological parameters in gastric cancer patients

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 44,No. 24

25. Association of preoperative platelet distribution width with clinicopathologic features and prognosis of gastric cancer patients

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 45,No. 25

26. Analysis of clinical adverse reactions of apatinib for the treatment of malignant tumors

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 45,No. 26

27. Analysis of clinical characteristics and prognosis of 63 cases of pancreatic neuroendocrine tumor

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 44,No. 27

28. Clinical Analysis of Rituximab-induced Interstitial Pneumonia

Chinese Journal of Clinical Oncology,Part 3: Clinical Study,Vol 43,No. 28